AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 253: H1372-H1380, 1987;
0363-6135/87 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolli, R.
Right arrow Articles by Roberts, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolli, R.
Right arrow Articles by Roberts, R.

AJP - Heart and Circulatory Physiology, Vol 253, Issue 6 1372-H1380, Copyright © 1987 by American Physiological Society

ARTICLES

The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction

R. Bolli, B. S. Patel, W. X. Zhu, P. G. O'Neill, C. J. Hartley, M. L. Charlat and R. Roberts
Department of Medicine, Baylor College of Medicine, Houston, Texas 77030.

Recent evidence suggests that postischemic myocardial dysfunction ("stunning") may be mediated by oxygen free radicals, but the mechanism by which they produce myocellular damage remains unknown. Since iron catalyzes formation of hydroxyl radicals (HO.) as well as HO.-initiated lipid peroxidation, we explored the potential role of this metal in the pathogenesis of myocardial stunning. Open-chest dogs undergoing a 15-min occlusion of the left anterior descending coronary artery (LAD) followed by 4 h of reperfusion (REP) received the iron chelator desferrioxamine intravenously (10 mg/kg over 45 min beginning 30 min before occlusion, then 1.7 mg.kg-1.h-1 throughout REP, n = 19) or normal saline (n = 17). Regional myocardial function was assessed by measuring systolic wall thickening with an epicardial Doppler probe. The two groups exhibited comparable systolic thickening under base-line conditions and similar degrees of dyskinesis during ischemia. After REP, however, recovery of contractile function (expressed as percent systolic thickening) as considerably greater in desferrioxamine-treated compared with control dogs: 5 +/- 3 (mean +/- SE) vs. -3 +/- 2% (P less than 0.05) at 1 h, 6 +/- 3 vs. -2 +/- 3% (P less than 0.05) at 2 h, 5 +/- 3 vs. -6 +/- 2% (P less than 0.005) at 3 h, and 6 +/- 3 vs. -6 +/- 2% (P less than 0.002) at 4 h. These differences could not be ascribed to hemodynamic factors. The results suggest that iron-catalyzed reactions (possibly HO. generation) play a significant role in myocardial stunning after a brief episode of reversible regional ischemia.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. T. Colston, B. Chandrasekar, and G. L. Freeman
A Novel Peroxide-induced Calcium Transient Regulates Interleukin-6 Expression in Cardiac-derived Fibroblasts
J. Biol. Chem., June 21, 2002; 277(26): 23477 - 23483.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Nitenberg, S. Ledoux, P. Valensi, R. Sachs, and I. Antony
Coronary Microvascular Adaptation to Myocardial Metabolic Demand Can Be Restored by Inhibition of Iron-Catalyzed Formation of Oxygen Free Radicals in Type 2 Diabetic Patients
Diabetes, March 1, 2002; 51(3): 813 - 818.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. A. Kloner and R. B. Jennings
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1
Circulation, December 11, 2001; 104(24): 2981 - 2989.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
R. Bolli and E. Marban
Molecular and Cellular Mechanisms of Myocardial Stunning
Physiol Rev, April 1, 1999; 79(2): 609 - 634.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T.-S. Lee, M.-S. Shiao, C.-C. Pan, and L.-Y. Chau
Iron-Deficient Diet Reduces Atherosclerotic Lesions in ApoE-Deficient Mice
Circulation, March 9, 1999; 99(9): 1222 - 1229.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
N. A. McHugh, G. F. Merrill, and S. R. Powell
Estrogen diminishes postischemic hydroxyl radical production
Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H1950 - H1954.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Nitenberg, F. Paycha, S. Ledoux, R. Sachs, J.-R. Attali, and P. Valensi
Coronary Artery Responses to Physiological Stimuli Are Improved by Deferoxamine but not by L-Arginine in Non–Insulin-Dependent Diabetic Patients With Angiographically Normal Coronary Arteries and No Other Risk Factors
Circulation, March 3, 1998; 97(8): 736 - 743.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
H. Mekhfi, V. Veksler, P. Mateo, V. Maupoil, L. Rochette, and R. Ventura-Clapier
Creatine Kinase Is the Main Target of Reactive Oxygen Species in Cardiac Myofibrils
Circ. Res., June 1, 1996; 78(6): 1016 - 1027.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. A. Araujo, E. L. Romano, B. E. Brito, V. Parthe, M. Romano, M. Bracho, R. F. Montano, and J. Cardier
Iron Overload Augments the Development of Atherosclerotic Lesions in Rabbits
Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1172 - 1180.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
G. Drossos, A. Lazou, P. Panagopoulos, and S. Westaby
Deferoxamine Cardioplegia Reduces Superoxide Radical Production in Human Myocardium
Ann. Thorac. Surg., January 1, 1995; 59(1): 169 - 172.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online